Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Brenner et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69d56c3f75589c71d767cd30 — DOI: https://doi.org/10.1056/nejmoa011161

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes· 2001 · 5,987 citations
2. Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients· 2000 · 8,654 citations
3. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.· 1994 · 224 citations
4. A Multiple Testing Procedure for Clinical Trials· 1979 · 3,340 citations
5. Nonparametric Estimation from Incomplete Observations· 1992 · 45,543 citations